17-63477152-TTGCTGCTGCCG-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_000789.4(ACE):βc.59_69delβ(p.Leu20SerfsTer19) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000902 in 1,440,834 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (β β ).
Frequency
Genomes: π 0.0000067 ( 0 hom., cov: 31)
Exomes π: 0.0000093 ( 0 hom. )
Consequence
ACE
NM_000789.4 frameshift
NM_000789.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.15
Genes affected
ACE (HGNC:2707): (angiotensin I converting enzyme) This gene encodes an enzyme involved in blood pressure regulation and electrolyte balance. It catalyzes the conversion of angiotensin I into a physiologically active peptide angiotensin II. Angiotensin II is a potent vasopressor and aldosterone-stimulating peptide that controls blood pressure and fluid-electrolyte balance. This angiotensin converting enzyme (ACE) also inactivates the vasodilator protein, bradykinin. Accordingly, the encoded enzyme increases blood pressure and is a drug target of ACE inhibitors, which are often prescribed to reduce blood pressure. This enzyme additionally plays a role in fertility through its ability to cleave and release GPI-anchored membrane proteins in spermatozoa. Many studies have associated the presence or absence of a 287 bp Alu repeat element in this gene with the levels of circulating enzyme. This polymorphism, as well as mutations in this gene, have been implicated in a wide variety of diseases including cardiovascular pathophysiologies, psoriasis, renal disease, stroke, and Alzheimer's disease. Regulation of the homologous ACE2 gene may be involved in progression of disease caused by several human coronaviruses, including SARS-CoV and SARS-CoV-2. Alternative splicing results in multiple transcript variants encoding both somatic (sACE) and male-specific testicular (tACE) isoforms. [provided by RefSeq, Sep 2020]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant located near the start codon (<100nt), not predicted to undergo nonsense mediated mRNA decay. There are 17 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 17-63477152-TTGCTGCTGCCG-T is Pathogenic according to our data. Variant chr17-63477152-TTGCTGCTGCCG-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 2634506.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACE | NM_000789.4 | c.59_69del | p.Leu20SerfsTer19 | frameshift_variant | 1/25 | ENST00000290866.10 | NP_000780.1 | |
ACE | NM_001382700.1 | c.-177_-167del | 5_prime_UTR_variant | 1/22 | NP_001369629.1 | |||
ACE | NM_001382701.1 | c.-556_-546del | 5_prime_UTR_variant | 1/23 | NP_001369630.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACE | ENST00000290866.10 | c.59_69del | p.Leu20SerfsTer19 | frameshift_variant | 1/25 | 1 | NM_000789.4 | ENSP00000290866 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000666 AC: 1AN: 150250Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
1
AN:
150250
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000631 AC: 5AN: 79280Hom.: 0 AF XY: 0.0000219 AC XY: 1AN XY: 45614
GnomAD3 exomes
AF:
AC:
5
AN:
79280
Hom.:
AF XY:
AC XY:
1
AN XY:
45614
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000930 AC: 12AN: 1290584Hom.: 0 AF XY: 0.00000943 AC XY: 6AN XY: 636330
GnomAD4 exome
AF:
AC:
12
AN:
1290584
Hom.:
AF XY:
AC XY:
6
AN XY:
636330
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000666 AC: 1AN: 150250Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 73358
GnomAD4 genome
AF:
AC:
1
AN:
150250
Hom.:
Cov.:
31
AF XY:
AC XY:
0
AN XY:
73358
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
ACE-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 03, 2023 | The ACE c.59_69del11 variant is predicted to result in a frameshift and premature protein termination (p.Leu20Serfs*19). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.032% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/17-61554513-TTGCTGCTGCCG-T). Frameshift variants in ACE are expected to be pathogenic. This variant is interpreted as likely pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 23, 2023 | This sequence change creates a premature translational stop signal (p.Leu20Serfs*19) in the ACE gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ACE are known to be pathogenic (PMID: 22095942). This variant is present in population databases (rs752411292, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with ACE-related conditions. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at